国家医保局发布受贿案案例 益佰制药业务员涉案

Group 1 - The National Healthcare Security Administration of China released a court criminal judgment excerpt regarding a bribery case involving Liu Mouhong, the director of the pharmacy department at Shuangshan Hospital in Anshan City [1] - Liu Mouhong utilized his position to assist others in drug procurement and increasing procurement volume [1] - The case is linked to Guizhou Yibai Pharmaceutical Co., Ltd., where a salesperson was involved in ensuring the supply of a specific product while excluding competitors [3] Group 2 - The judgment revealed that Liu Mouhong accepted a total of 6,000 yuan from a salesperson to facilitate the procurement of Yibai Pharmaceutical's Ginkgo Biloba injection [3] - The bribery occurred in September 2015 and January 2016, just before the Spring Festival [3] - The case highlights issues of corruption within the pharmaceutical procurement process in Chinese hospitals [3]